The International Neuromodulation Society

The Fastest-Growing, Worldwide Multidisciplinary Body Devoted to Building Knowledge of Neuromodulation

The International Neuromodulation Society (INS) is a non-profit group of clinicians, scientists and engineers dedicated to the scientific development and awareness of neuromodulation – the alteration of nerve activity through targeted delivery of a stimulus, such as electrical stimulation or chemical agents, to specific neurological sites in the body. The San Francisco-based INS was formed in 1989 and educates and promotes the field through meetings, its peer-reviewed journal Neuromodulation: Technology at the Neural Interface, explanatory content, and chapter websites. The INS also provides information for patients and produces rolling news briefs about this rapidly evolving field.

The INS Peer-Reviewed Journal – 8 Issues a Year

The INS journal Neuromodulation: Technology at the Neural Interface has a growing Impact Factor and is indexed in Index Medicus, MEDLINE and Pubmed from its first issue in 1998. Members may log in to the members-only section to read the journal online.

journal cover

+Submit a Manuscript.+

What is Neuromodulation?

Medical Professionals can learn about various considerations concerning neuromodulation and clinic contacts. Once your preliminary questions have been answered, please use the Contact Us facility to find out more and to discuss specific objectives. Others may simply wish to join the INS and one of its related chapter societies, please use the Membership Application.

Clinical trials that involve a wide range of emerging neuromodulation approaches are listed on our Research page. Neuromodulation clinical trials address symptom control through nerve stimulation in such condition categories as:

If you are not a medical professional and you are searching for information about neuromodulation and how these types of treatment could benefit a specific condition such as treatment-resistant headache or other chronic pain syndromes, you may find the sections titled Therapies, About Neuromodulation or FAQs particularly helpful.

Members may log in and visit the members-only section’s Global Discussion Forum

Breaking News Share

Deep Brain Stimulation Implantation Performed Remotely Over 5G Mobile Network in China

March 18, 2019 - A surgeon in China used a 5G mobile network to guide remote-control robots for implantation of deep brain stimulation leads in a Parkinson's disease patient 1,800 miles away in Beijing. (Daily Mail)

Maker of Stimulation Device for Acute Migraine Raises $35 Million in Series B Funding

March 18, 2019 - The Israeli company Theranica announced it has raised $35 million in a Series B round of funding. The company is making a wearable stimulation device for acute migraine. (PE Hub Network)

Data Presented in Small Case Series about Effect of Intranasal Stimulator on Ocular Pain

March 18, 2019 - An abstract presented at the 2018 World Congress on Pain concerned a small case series in which patients with persistent post-herpetic eye pain received a dose of intranasal stimulation during an office visit, to investigate observations made in patients who used the device for dry eye and noticed an impact on their corneal pain. (Pain Medicine News)

Noninvasive or Minimally Invasive Technology is Intended to Target Chronic Pain

March 16, 2019 - An article describes a mask that delivers sound and light stimuli based on heart rate to potentially address some chronic pain; the article mentions other noninvasive or subcutaneous devices that provide stimulation to treat different types of pain. (CNBC)

To see select neuromodulation news by category, as well as news about the INS in particular, please visit the Newsroom. To see archived news briefs dating back to January 2011, visit the News Archive.

Continue Reading News Briefs
Last Updated on Monday, December 12, 2016 10:01 AM